Cancer Epidemiology Biomarkers & Prevention, Vol 6, Issue 7 511-515, Copyright © 1997 by American Association for Cancer Research

ARTICLES

Glutathione S-transferase class mu deletion polymorphism and breast cancer: results from prevalent versus incident cases

KT Kelsey, SE Hankinson, GA Colditz, K Springer, M Garcia-Closas, D Spiegelman, JE Manson, M Garland, MJ Stampfer, WC Willett, FE Speizer and DJ Hunter
Department of Cancer Biology, Harvard School of Public Health, Boston, MA 02115, USA.

A common deletion polymorphism in the gene coding for the glutathione S-transferase class mu (the GSTM1 gene) results in a decreased ability to detoxify carcinogenic epoxide intermediates and has been associated with increased breast cancer risk in some small studies. We studied the GSTM1 gene deletion polymorphism (conferring the null genotype) in 243 women who had prevalent breast cancer and 245 women without breast cancer, who were among the 32,826 women in the Nurses' Health Study who gave a blood sample in 1989-1990. In the prevalent case series, the null genotype was slightly more common among cases (58%) than among controls (51%; age-adjusted odds ratio = 1.30; 95% confidence interval, 0.91-1.86). Among cases, the prevalence of the GSTM1 deletion increased with duration of survival [68% for > or = 8 years since diagnosis; 57% for 4-8 years; 51% for < 4 years; P (trend) = 0.04]. In an incident case series of 240 women who were diagnosed with breast cancer following blood collection and prior to June of 1992 and compared with age-matched controls, the GSTM1 deletion was not associated with an elevation in risk (relative risk, 1.08; 95% confidence interval, 0.74-1.57). No significant interaction with cigarette smoking was evident. Thus, there was no significant increase in risk of incident breast cancer associated with the GSTM1 null genotype; however, the gene deletion polymorphism appeared to confer improved survival. These data suggest that odds ratios based upon prevalent cases in molecular epidemiologic studies may be biased due to differential survival. Further studies are required to determine whether this polymorphism is associated with improved breast cancer prognosis.

This article has been cited by other articles:

				A. T. Chan, J. Ma, G. J. Tranah, E. L. Giovannucci, N. Rifai, D. J. Hunter, and C. S. Fuchs Hemochromatosis Gene Mutations, Body Iron Stores, Dietary Iron, and Risk of Colorectal Adenoma in Women J Natl Cancer Inst, June 15, 2005; 97(12): 917 - 926. [Abstract] [Full Text] [PDF]

				M. R. Spitz, X. Wu, and G. Mills Integrative Epidemiology: From Risk Assessment to Outcome Prediction J. Clin. Oncol., January 10, 2005; 23(2): 267 - 275. [Abstract] [Full Text] [PDF]

				K. M. Egan, Q. Cai, X.-O. Shu, F. Jin, T.-L. Zhu, Q. Dai, Y.-T. Gao, and W. Zheng Genetic Polymorphisms in GSTM1, GSTP1, and GSTT1 and the Risk for Breast Cancer: Results from the Shanghai Breast Cancer Study and Meta-Analysis Cancer Epidemiol. Biomarkers Prev., February 1, 2004; 13(2): 197 - 204. [Abstract] [Full Text] [PDF]

				C. Sweeney, V. Nazar-Stewart, P. L. Stapleton, D. L. Eaton, and T. L. Vaughan Glutathione S-transferase M1, T1, and P1 Polymorphisms and Survival among Lung Cancer Patients Cancer Epidemiol. Biomarkers Prev., June 1, 2003; 12(6): 527 - 533. [Abstract] [Full Text] [PDF]

				M M de Jong, I M Nolte, G J te Meerman, W T A van der Graaf, J C Oosterwijk, J H Kleibeuker, M Schaapveld, and E G E de Vries Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility J. Med. Genet., April 1, 2002; 39(4): 225 - 242. [Abstract] [Full Text] [PDF]

				S. M. Schwartz, D. R. Doody, E. D. Fitzgibbons, S. Ricks, P. L. Porter, and C. Chen Oral Squamous Cell Cancer Risk in Relation to Alcohol Consumption and Alcohol Dehydrogenase-3 Genotypes Cancer Epidemiol. Biomarkers Prev., November 1, 2001; 10(11): 1137 - 1144. [Abstract] [Full Text] [PDF]

				J. L. Santos, F. Perez-Bravo, E. Carrasco, M. Calvillan, and C. Albala Association between HLA-DQB1 Alleles and Type 1 Diabetes in a Case-Parents Study Conducted in Santiago, Chile Am. J. Epidemiol., April 15, 2001; 153(8): 794 - 798. [Abstract] [Full Text] [PDF]

				K. Mitrunen, N. Jourenkova, V. Kataja, M. Eskelinen, V.-M. Kosma, S. Benhamou, H. Vainio, M. Uusitupa, and A. Hirvonen Glutathione S-Transferase M1, M3, P1, and T1 Genetic Polymorphisms and Susceptibility to Breast Cancer Cancer Epidemiol. Biomarkers Prev., March 1, 2001; 10(3): 229 - 236. [Abstract] [Full Text]

				A. Rundle, D. Tang, J. Zhou, S. Cho, and F. Perera The Association between Glutathione S-Transferase M1 Genotype and Polycyclic Aromatic Hydrocarbon-DNA Adducts in Breast Tissue Cancer Epidemiol. Biomarkers Prev., October 1, 2000; 9(10): 1079 - 1085. [Abstract] [Full Text]

				P. A. Thompson and C. Ambrosone Chapter 7: Molecular Epidemiology of Genetic Polymorphisms in Estrogen Metabolizing Enzymes in Human Breast Cancer J Natl Cancer Inst Monographs, July 1, 2000; 2000(27): 125 - 134. [Abstract] [Full Text] [PDF]

				R. Millikan, G. Pittman, C.-K. Tse, D. A. Savitz, B. Newman, and D. Bell Glutathione S-Transferases M1, T1, and P1 and Breast Cancer Cancer Epidemiol. Biomarkers Prev., June 1, 2000; 9(6): 567 - 573. [Abstract] [Full Text]

				M. Stanulla, M. Schrappe, A. M. Brechlin, M. Zimmermann, and K. Welte Polymorphisms within glutathione S-transferase genes (GSTM1, GSTT1, GSTP1) and risk of relapse in childhood B-cell precursor acute lymphoblastic leukemia: a case-control study Blood, February 15, 2000; 95(4): 1222 - 1228. [Abstract] [Full Text] [PDF]

				M. Garcia-Closas, K. T. Kelsey, S. E. Hankinson, D. Spiegelman, K. Springer, W. C. Willett, F. E. Speizer, and D. J. Hunter Glutathione S-Transferase Mu and Theta Polymorphisms and Breast Cancer Susceptibility J Natl Cancer Inst, November 17, 1999; 91(22): 1960 - 1964. [Abstract] [Full Text] [PDF]

				S. S. Coughlin and M. Piper Genetic Polymorphisms and Risk of Breast Cancer Cancer Epidemiol. Biomarkers Prev., November 1, 1999; 8(11): 1023 - 1032. [Full Text]

				A. M. Dunning, C. S. Healey, P. D. P. Pharoah, M. D. Teare, B. A. J. Ponder, and D. F. Easton A Systematic Review Of Genetic Polymorphisms and Breast Cancer Risk Cancer Epidemiol. Biomarkers Prev., October 1, 1999; 8(10): 843 - 854. [Abstract] [Full Text]

				V. Nazar-Stewart, T. L. Vaughan, R. D. Burt, C. Chen, M. Berwick, and G. M. Swanson Glutathione S-Transferase M1 and Susceptibility to Nasopharyngeal Carcinoma Cancer Epidemiol. Biomarkers Prev., June 1, 1999; 8(6): 547 - 551. [Abstract] [Full Text]

				C. B. Ambrosone, B. F. Coles, J. L. Freudenheim, and P. G. Shields Glutathione-S-transferase (GSTM1) Genetic Polymorphisms Do Not Affect Human Breast Cancer Risk, Regardless of Dietary Antioxidants J. Nutr., February 1, 1999; 129(2): 565 - 565. [Abstract] [Full Text] [PDF]